Fycompa

This page shows the latest Fycompa news and features for those working in and with pharma, biotech and healthcare.

Germany planning to table pricing reforms 'by the summer'

Eisai did likewise for its epilepsy treatment Fycompa (perampanel).

Eisai establishes neuroscience unit in Belgium and Luxembourg

The new unit will market the company's epilepsy drug Fycompa (perampanel), which it has been giving a rolling launch across the region. ... Fycompa indicated for the adjunctive treatment of partial onset seizures, with or without secondarily generalised
Eisai opens first office in Australia

New Melbourne base to support marketing of Halaven and Fycompa. Japan-based pharma firm Eisai has extended its global expansion with a new office in Melbourne, Australia. ... Fycompa is the first in a new class of treatment for partial onset seizures,
Eisai "speechless" as G-BA denies price premium for Fycompa

But company has better news on cancer drug Halaven. . Eisai's efforts to secure favourable pricing for its epilepsy drug Fycompa in Germany have hit the buffers once again. ... The German Federal Joint Committee (G-BA) has concluded once again that
Eisai backs competition to find star of epilepsy comic book

Epilepsy is a relative new area of focus for Eisai, whose treatment options include Fycompa (perampanel), which was launched in Europe in 2012.
Eisai ‘outraged’ by IQWIG’s failure to back epilepsy drug

Eisai has issued a damning statement criticising Germany's healthcare watchdog IQWIG for not backing epilepsy drug Fycompa. ... IQWIG's recommendation will now be considered by the G-BA, which is expected to published a decision on Fycompa's use in

More from news
Approximately 10 fully matching, plus 9 partially matching documents found.

Eisai: Bucking the trend with R&D growth

by adding a new solid dose global manufacturing line for its anti-epileptic medicine Fycompa. ... Fycompa was the first Eisai-developed epilepsy drug and it's “a drug we can really differentiate”, says Hendler.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Senior Account Executive with progression to Account Manager, Me...: Excellent package

Digital Communications Lead, Healthcare Brand and Medical Commun...: up to £50K

Senior Developer with management potential, Healthcare Brand Com...: circa £50K

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Manager - Immunology, Therapeutic Area Communications & Publ...: Competitive Salary Offered

Add my company

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Is China ready for a pharmaceutical gold rush?: Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance: Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis: Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...